Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors

Everolimus is a valid therapeutic option for neuroendocrine tumors (NETs); however, data in a real-world setting outside regulatory trials are sparse. The aim of this study was to determine everolimus tolerability and efficacy, in relation to previous treatments, in a compassionate use program. A to...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Panzuto, Francesco, Rinzivillo, Maria, Fazio, Nicola, de Braud, Filippo, Luppi, Gabriele, Zatelli, Maria Chiara, Lugli, Francesca, Tomassetti, Paola, Riccardi, Ferdinando, Nuzzo, Carmen, Brizzi, Maria Pia, Faggiano, Antongiulio, Zaniboni, Alberto, Nobili, Elisabetta, Pastorelli, Davide, Cascinu, Stefano, Merlano, Marco, Chiara, Silvana, Antonuzzo, Lorenzo, Funaioli, Chiara, Spada, Francesca, Pusceddu, Sara, Fontana, Annalisa, Ambrosio, Maria Rosaria, Cassano, Alessandra, Campana, Davide, Cartenì, Giacomo, Appetecchia, Marialuisa, Berruti, Alfredo, Colao, Annamaria, Falconi, Massimo, Delle Fave, Gianfranco
বিন্যাস: Artigo
ভাষা:Inglês
প্রকাশিত: AlphaMed Press 2014
বিষয়গুলি:
Gastrointestinal Cancer
অনলাইন ব্যবহার করুন:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153458/
https://ncbi.nlm.nih.gov/pubmed/25117065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0037
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

অনুরূপ উপাদানগুলি